Utama › Penyakit Sel Sabit › Maryland
Kajian klinikal Penyakit Sel Sabit di Maryland
17 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03937817Blood Sampling for Research Related to Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT00542230Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa awal 1
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06313398A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- The Johns Hopkins University School of Medicine, Baltimore
Mengambil pesertaFasa 3
Umur 12 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06439082Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05170412Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05904093Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 99 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06944067SCD Stem Cell Mobilization and Apheresis Using Motixafortide
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1/2
Umur 4 hingga 65 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07599176Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 18 hingga 90 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07566494A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0064, Baltimore
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Johns Hopkins University Hemophilia Treatment Center, Baltimore
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Maryland, Baltimore
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Center for Cancer and Blood Disorders, Bethesda
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
Mengambil pesertaFasa 3
Umur 10 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06975865Cooperative Assessment of Late Effects for SCD Curative Therapies
- Johns Hopkins Hospital, Baltimore
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 4 hingga 65 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05153967Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
- University of Maryland Medical Systems, Baltimore
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Dis 2025 · NCT06184126Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.